News & Media: Abstract Library

THE MEDICAL COMMUNITY CONTINUES TO RESEARCH AND SHARE EXPERIENCES WITH THE RECELL® SYSTEM

Extensive research has been conducted and distributed for public review, including the following abstracts presented at medical meetings and symposia.

2020

  • Presentation: Qiao. Application of epidermal cell transplantation in post-burn scar treatment. 2020 January; Annual Meeting of Sichuan Plastic Cosmetology Association; Chengdu, China.
  • Presentation: J Carter. Autologous Skin Cell Suspension Reduces Length of Stay for Burn Injuries. 2020 January; EAST (Association for the Surgery of Trauma)
  • Presentation: Roop. State of the art iPSCs. 2020 Jan 19-23; EB 20202; London, UK.
  • Presentation: K Foster. Treatment of Donor Sites in Large TBSA Burn Injuries with an Autologous Skin Cell Suspension. 2020 January 25-30; Boswick; Maui, HI.
  • Presentation: K Foster. Health Economic Assessment of Autologous Skin Cell Suspension using Contemporary Real-World Burn Care Data. 2020 January; Boswick; Maui, HI.
  • Presentation: A Savetamal. Analysis of Current Real-World Burn Care Practice Patterns Compared to National Burn Registry. 2020 January. Boswick; Maui, HI
  • Presentation: N Kopari. he Faces of Autologous Skin Cell Suspension as Epidermal Grafts. 2020 January 25-30; Boswick; Maui, HI.
  • Presentation: Ellis. Use of Suprathel to Cover Donor Sites Treated with Autologous Regenerative Epidermal Suspension. 2020 January 25-30; Boswick; Maui, HI.
  • Poster: K Bush. Design of a Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of Autologous Skin Cell Suspension Combined with Meshed Autograft for Reduction of Donor Area in Soft Tissue Reconstruction. 2020 January 25-30; Boswick; Maui, HI.
  • Presentation: A Bright. Video presentation of a disruptive innovation: Autologous cell solution for skin grafting in the burn patient. 2020 February 8-11; Southeastern Surgical Congress; New Orleans, LA.
  • Presentation: K Foster. Treatment of Donor Sites in Large TBSA Burn Injuries with an Autologous Skin Cell Suspension Supports Early Reharvesting. 2020 February 15-20; North American Burn Society; Sun Valley, ID.
  • Presentation: K Larson. The Use of RECELL® Spray-On Skin™ Cells in the Treatment of Facial Burns. 2020 February 15-20; North American Burn Society; Sun Valley, ID.
  • Presentation: A Quick. Design of a Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of Autologous Skin Cell Suspension Combined with Meshed Autograft for Reduction of Donor Area in Soft Tissue Reconstruction. 2020 February 15-20; North American Burn Society; Sun Valley, ID.
  • Presentation: Olivi. Use of Sprayed Autologous Skin Cell Suspension (ASCS) in Large Deep Partial Thickness Burn. 2020 February 15-20; North American Burn Society; Sun Valley, ID.
  • Presentation: Olivi. Biodegradable Dermal Matrix in Conjunction with Meshed and Sprayed Autologous Cell Suspension with a Vacuum Assisted Dressing Achieved Limb Salvage in 73 y/o with Deep full thickness Burn Despite Exposed Tendon and Bone. 2020 February 15-20; North American Burn Society; Sun Valley, ID.
  • Presentation: J. Litt. Evaluating current real-world national and regional definitive closure trends in burn care, including health economic outcomes with autologous skin cell suspension use. 2020 February; North American Burn Society Meeting; Sun Valley, ID.
  • Presentation: J Carter. Reduced Length of Stay with Autologous Skin Cell Suspension. 2020 March; American Burn Association.
  • Poster: J Carter. Post-Operative Wound Care Using Silver-Based Dressing with Autologous Skin Cell Suspension. 2020 March; American Burn Association.
  • Presentation: K Foster. Treatment of Donor Sites in Large TBSA Burn Injuries with an Autologous Skin Cell Suspension Supports Early Reharvesting. 2020 March; American Burn Association.
  • Presentation: K Foster. The Changing State of US Burn Care: Summarizing Current Burn Care Trends and Valuing New Interventions. 2020 March; American Burn Association.
  • Poster: J Holmes. Real World Treatment Trends for Patients TBSA ≤ 20%: Evaluating Important Shifts in Care and Budget Impact of ASCS Adoption. 2020 March; American Burn Association.
  • Presentation: Kowal. Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients: Analysis of the American Burn Association National Burn Repository. 2020 March; American Burn Association.
  • Poster: N Kopari. Autologous Skin Cell Suspension in Combination with Meshed Autograft: A Case Report Demonstrating the Efficacy in NSTI. 2020 March; American Burn Association.
  • Poster: N Kopari. The Faces of Autologous Skin Cell Suspension as Epidermal Grafts. 2020 March; American Burn Association.
  • Poster: Chattopadhyay. Autologous Skin Cell Suspension May Enhance Healing of Burn Wounds and Skin Graft Donor Sites in Elderly Burn Patients. 2020 March; American Burn Association.
  • Poster: Olivi. Use of a Biodegradable Dermal Matrix in Conjunction with Meshed and Sprayed Autologous Cell Suspension with a Vacuum Assisted Dressing Achieved Limb Salvage in a 73 Year Old with Deep Full Thickness Burns Despite Exposed Tendon and Bone. 2020 March; American Burn Association.

2019

  • PRESENTATION: K Larson. Treatment of a Full-Thickness Burn Injury with Biodegradable Temporizing Matrix and Autologous Skin Cell Suspension: A Case Report. Presented at North American Burn Society; 2019 January 19-24; Park City, Utah, USA
    CTP004
  • PRESENTATION: K Foster. The Health Economic Impact of Introducing a Novel Technology into the Burn Center: A Case Study with Autologous Cell Harvesting Device. Presented at North American Burn Society; 2019 January 19-24; Park City, Utah, USA
  • PRESENTATION: J Holmes (Presented by K Foster). Establishing the Safety and Efficacy of RECELL™ as an Autograft Sparing Technology for Definitive Closure of Burn Injuries. Presented at North American Burn Society; 2019 January 19-24; Park City, Utah, USA
  • PRESENTATION: J Sparks. Avita Medical – Cost-effectiveness of RECELL® Autologous Cell Harvesting Device (ACHD) vs STSG for Treatment of Severe Burns in the United States. Presented at North American Burn Society; 2019 January 19-24; Park City, Utah, USA.
  • PRESENTATION: A Quick. Avita Medical – Evaluation of RECELL® in patients aged 1-16 years: Clinical Protocols for two Pivotal, Pediatric, Prospective Randomized Controlled Trials. Presented at North American Burn Society; 2019 January 19-24; Park City, Utah, USA.
  • PRESENTATION: K Winn. Avita Medical – Overview of the RECELL® Device: Obtain, Prepare, Deliver. Presented at North American Burn Society; 2019 January 19-24; Park City, Utah, USA.
  • PRESENTATION: B Platt. Autologous Skin Cell Suspension Reduces Length of Stay for Burn Injuries. Presented at Louisiana American College of Surgeons. January 2019.
  • PRESENTATION: W Hickerson. A Comparative Study of Autologous Skin Cell Suspension to Split-thickness Skin Grafts in the Treatment of Deep Partial-thickness Acute Burn Wounds. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: J Carter. Combining RECELL® with Meshed Autografts Reduces Donor Skin Requirements for the Treatment of Full-Thickness Burn Wounds. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: J Carter. Use of a Biodegradable Polyurethane Dermal Substitute in Severe Injuries: A case series of various mechanisms and outcomes. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: K Foster. The Health Economic Impact of Introducing a Novel Technology into the Burn Center: A Case Study with Autologous Cell Harvesting Device. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: K Foster. Compassionate Use of an Autologous Skin Cell Suspension in a Patient with a Large Soft Tissue Defect Due to a Necrotizing Soft Tissue Infection. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: R Sood. A Prospective Evaluation of RECELL® in Compassionate Use: Experience with the Use of RECELL® to Treat Large TBSA Injuries. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • POSTER: K Bush. Evaluation of RECELL® in Patients Aged 1 – 16 Years: Clinical Protocols for Two Pivotal, Pediatric, Prospective Randomized Controlled Trials. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: Use of Suprathel + RECELL®. Presented at Boswick Symposium; 2019 February 2-7; Maui, Hawaii, USA.
  • PRESENTATION: F. Wood. New progress in the application of RECELL® technology in medicine. Presented at The 18th International Congress of Plastic & Reconstructive Surgery; 2019 March 10-17; Shanghai, CHINA.
  • PRESENTATION: J Molnar. Evaluation of Autologous Skin Cell Suspension for Healing of Burn Injuries of the Hand. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    CTP004
  • PRESENTATION: J Carter. Evaluation of Pediatric Population Treated for Burn Injuries Using an Autologous Skin Cell Suspension. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    CTP004
  • PRESENTATION: Christopher K. Craig, MMS, PA-C; Jeffery W. Williams, MMS, PA-C; Christopher G. Barone, BSN, RN; Michaela M. Aitken, BSN, RN; Jeffrey E. Carter, MD; Joseph A. Molnar, MD; James H. Holmes IV, MD. Post-Operative Wound Management Following the Use of RECELL® Autologous Cell Harvesting Device in the Treatment of Patients with Life-Threatening Injuries: A Single Center’s Experience. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    CTP004
  • PRESENTATION: F Wood. 10 years of clinical experience using point of care non cultured autologous skin cell suspension harvested using the RECELL® device. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
  • POSTER: DY Nakamura OTR/L, CLT; ED Richardson PT, DPT; CK Craig, MMS, PA-C; J Williams, MMS, PA-C; JE Carter, MD; JA Molnar, MD, PhD; JH Holmes IV, MD This is How We Do It: Rehabilitation Following the Use of RECELL® Autologous Cell Harvesting Device. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    CTP004
  • POSTER: K Foster. Healing of Donor Sites with an Autologous Skin Cell Suspension Enables Early Reharvesting for Large TBSA Burn Injuries: A Prospective Evaluation. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    CTP004
  • POSTER: K Foster. Budget impact of autologous cell harvesting device (ACHD) use versus standard of care (SOC) for treatment of severe burns: A case study for the Arizona Burn Center. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    HECON
  • POSTER: Chang KM BA, Levin JM BS, Sangji NF MD MPH, Ryan CM MD, Schulz JT III MD PhD, Sheridan R MD, Friedstat JS MD, Goverman J MD FACS. Autologous Regenerative Epidermal Suspension (RES™): A Case Study. Presented at American Burn Association (ABA); 2019 April 2-5; Las Vegas, NV, USA.
    CTP004
  • PRESENTATION: C Harris, T Randawa, P Muthayya, A Phipps, B Sloan, A Carter, J Yarwood, R Sandhu. Management following rapid enzymatic debridement of burn wounds, our experience with use of keratinocyte suspension spray. Presented at British Burns Association (BBA); 2019 May 8-10; Leeds, UK
  • POSTER: O Hausien, C Lewis, K Allison. The RECELL® system for resurfacing of acute burn wounds: a systematic review. Presented at British Burns Association (BBA); 2019 May 8-10; Leeds, UK
  • PRESENTATION: Z. Liu Treatment strategies for acne scars. The 16th National Medical Aesthetics Conference of the Chinese Medical Association (CSMAC) 2019; 2019 May 10-12 Shanghai, China.
  • PRESENTATION: J Genevieve Park, PhD, MD, Sita M. Damaraju, PhD, Benjamin R. Mintz, PhD, Ankur S. Gandhi, PhD, Sunil Saini, PhD, Ronald Ingram, PhD, Joseph A. Molnar, PhD, MD. COLLAGEN MATRICES AND AUTOLOGOUS CELLS SUSPENSION DIFFERENTIALLY INFLUENCE RE-EPITHELIALIZATION AT 2 WEEKS IN A PORCINE WOUND MODEL; Presented at Wound Healing Society; 2019 May 10; San Antonio, TX, USA.
    Pre-clinical
  • POSTER: Li Wei Wei. Is suction blister epidermal grafting a simple and reliable way to screen patients with large area vitiligo for RECELL® treatment Presented at World Congress of Dermatology; 2019 June 10-15; Milan, Italy.
  • POSTER: Lui Zhifei. Spontaneous pigmentation spots are signs of successful RECELL® therapy in patients with stable large area vitiligo. Presented at World Congress of Dermatology; 2019 June 10-15; Milan, Italy.
  • POSTER: Yanze Nu. Is suction blister epidermal grafting a simple and reliable way to screen patients with large area vitiligo for RECELL® treatment Presented at World Congress of Dermatology; 2019 June 10-15; Milan, Italy.
  • PRESENTATION: Tawqeer Rashid, MD. A Feasibility Study of the RECELL® Autologous Cell Harvesting Device for Diabetic Foot Ulcers. The congress of the Japan Society of Limb Salvage & Podiatric Medicine (JSLSPM)​; 2019 June 28-29; Kobe, Japan.
  • PRESENTATION: Qiao – RECELL® experience. Presented at Wound prevention and tissue repair professional committee of Chinese Research Hospital Association conference. September 19-22 2019.
  • PRESENTATION: Rajiv Sood. A Prospective Evaluation of Spray Keratinocytes and Cultured Keratinocytes to Treat Large TBSA Injuries. European Burns Association; 2019 September 7-9; Helsinki, Finland.
  • PRESENTATION: Anjay Khandelwal. Assessing the Health Economic Outcomes associated with autologous skin cell suspension (ASCS) use using real world rational and regional data for definitive closure. Presented at Eastern Great Lakes Region Burn Conference; 2019 September 25-26; Pittsburgh, PA.
  • PRESENTATION: Jeffrey Litt. Innovations in Regenerative Medicine for Large Body Surface Area Burns – Can We Do More with Less? Presented at Midwestern Region Burn Conference; 2019 October 3-4; Iowa City, IA.
  • PRESENTATION: Jeffrey Litt. Evaluating Real World National & Regional Definitive Closure Trends in Burn Care, Including Health Economic Outcomes with Autologous Skin Cell Suspension. Presented at Midwestern Region Burn Conference; 2019 October 3-4; Iowa City, IA.
  • PRESENTATION: Abe Huong. Treatment of Severe Burns with ASCS and Meshed Autograft with Allograft Overlay. Presented at Northeast Region Burn Conference; 2019 November 10-11; Portland, ME.
  • PRESENTATION: Alisa Savetamal. Treatment of Severe Burns with Autologous Skin Cell Suspension & Meshed Autograft with Allograft. Presented at Northeast Region Burn Conference; 2019 November 10-11; Portland, ME.
  • PRESENTATION: Alisa Savetamal. Evaluating the health economic outcomes of autologous skin cell suspension (ASCS) using real world national and regional benchmark data. Presented at Northeast Region Burn Conference; 2019 November 10-11; Portland, ME.
  • PRESENTATION: B Platt. Autologous Skin Cell Suspension Reduces Length of Stay for Burn Injuries. Presented at Louisiana American College of Surgeons. January 2019.
  • PRESENTATION: JH Sojka. Newer closure Techniques for very large burns and their application on a single patient with 73% TBSA full thickness burns. Presented at Northeast Region Burn Conference; 2019 November 10-11; Portland, ME.
  • POSTER: C Austin. Treatment of a Full Thickness Burn Injury with Biodegradable Temporizing Matrix and Autologous Skin Cell Suspension: A Case Report. Presented at SOCRA 2019.
  • Presentation: W Yunchuan. Clinical observation of epidermal cell implantation in promoting the healing of donor skin in children. Presented at Chinese Burns Association; 2019 November 6-9; Zhuhai, China.
  • Presentation: W Hickerson. Evaluating real world national and regional definitive closure trends in burn care, including health economic outcomes with autologous skin cell suspension use. Southern Region Burn Conference; 2019 December 5-8; San Antonio, TX.
  • Presentation: D Nakamura. An Algorithm for Therapy Following Autologous Skin Cell Suspension Grafting. Southern Region Burn Conference; 2019 December 5-8; San Antonio, TX.
  • Presentation: J Carter. Post-Operative Wound Care Using Silver-Based Dressing with Autologous Skin Cell Suspension. Southern Region Burn Conference; 2019 December 5-8; San Antonio, TX.
  • Poster: J Sojka. Newer Closure Techniques for Very Large Burns and Their Application on a Single Patient with 73% TBSA Full Thickness Burns. Southern Region Burn Conference; 2019 December 5-8; San Antonio, TX.

2018

  • PRESENTATION: K Foster. Compassionate use of RECELL® and Meshed Autografts in Patients with Extensive Burn Injury, John A. Boswick Burn & Wound Care Symposium, 2018 Wailea Beach Resort Maui, Jan 28-Feb 01, HI, USA.
    CTP004
  • PRESENTATION: K Foster, MD. New Technologies: StrataGraft and RECELL®. Presented at the Western Region Burn Conference, 2018 Jan 10-13; Breckenridge, CO, USA.
    CTP004
  • PRESENTATION: K Foster, MD. Compassionate use of RECELL® and meshed autografts in patents with extensive burn injury. Presented at the North American Burn Association Symposium (NABS), 2018 March 10-15; Steamboat Springs, CO, USA.
  • PRESENTATION: B. Hartman, M. Zieger, D. Roggy, R. Sood.  A Prospective Evaluation of Spray Keratinocytes to Treat Large TBSA Injuries.  Presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    CTP004
  • PRESENTATION: NJ Walker, RE Rebowe, L. Allred, CK Craig, J. Williams, JH Holmes, JE Carter, JA Molnar. Initial Experience with Autologous Cell Suspension for Treatment of Partial Thickness Facial Burns.  Presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    CTP004
  • PRESENTATION: Hickerson, MD, JA Molnar, JE Carter, BA Cairns, J Hwang, BT King, CW Cruse, DJ Smith, Sood, MJ Feldman, DG Greenhalgh, TL Palmieri, S Dissanaike, JA Griswold, MD Peck, KN Foster, DW Mozingo, MH Jordan, JH Holmes IV. A Comparative Study of Autologus Skin Cell Suspension to Split-thickness Autografting in the Treatment of Acute Burns (RECELL®-5).  Presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    CTP001-5
  • PRESENTATION: JH Holmes IV, JE Carter, JA Molnar, BA Cairns, J Hwang, BT King, JW Shupp, WL Hickerson, MD, K Foster.  Demonstration of the Safety and Effectiveness of Autologous Skin Cell Suspension Combined with Meshed Skin Grafts for the Reduction of Donor Area in the Treatment of Acute Burns. Presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    CTP001-6
  • PRESENTATION: JG Park, SM Damaraju, BR Mintz, A Gandhii, S Saini, R Ingram, J Molnar. Validation and Characterization of an Immediate, One-Stage Technique to Treat Full-Thickness Wounds in Swine. Presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    Pre-clinical Study
  • POSTER: K Foster, P Bilir, E Kruger, S Kowal, W Hickerson, J Holmes, S Nystrom, D Turley, J Sparks, N Iyer, A Quick.Cost-effectiveness of an Autologous Regenerative Epithelial Suspension versus Standard of Care for Treatment of Severe Burns in the United States.  Poster presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    Health Econ
  • POSTER: B Hartman, M Zieger, D Roggy, R Sood. A Prospective Evaluation of Spray Keratinocytes to Treat Large TBSA Injuries. Poster presented at American Burn Association (ABA); 2018 April 10-13; Chicago, IL, USA.
    CTP004
  • PRESENTATION: P Bilir. Inpatient Cost of Acute Care for Severe Burn Patients: Validation of Economic Model for Adults and Children. Presentation at International Society for Pharmacoeconomics and Outcomes (ISPOR); 19-23 May 2018; Baltimore, MD.
  • PRESENTATION: E Kruger. Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients: Analysis of the American Burn Association National Burn Repository. Presentation at International Society for Pharmacoeconomics and Outcomes (ISPOR); 19-23 May 2018; Baltimore, MD.
  • SESSION: J Carter. Establishing the Effectiveness of RECELL® for Definitive Closure or Burn Injuries. Presented at 2nd Changhai Academic Week for Burns Treatment; 2018 June 22-24; Pudong, Shanghai, China.
    CPT001-5/-6, CPT004
  • PRESENTATION: J Holmes. Establishing the Safety and Effectiveness of RECELL® as an Autograft-sparing Technology for Definitive Closure of Burn Injuries. Presentation at Military Health System Research Symposium (MHSRS); 2018 August; Florida.
  • PRESENTATION: J Carter. Establishing the Safety and Effectiveness of RECELL® as an Autograft-sparing Technology for Definitive Closure of Burn Injuries. Presented at Eastern Great Lakes Region Burn Conference 2018; 2018 September 20-21; Ann Arbor, MI, USA.
    CPT001-5/-6
  • PRESENTATION: J Carter. Establishing the Effectiveness of RECELL® as an Autograft-Sparing Technology for Definitive Closure of Burn Injuries. Presented at Midwestern Burn Conference 2018; 2018 October 11-12; Minneapolis, MN, USA.
    CPT001-5/-6
  • PRESENTATION & Poster: Anjana Bairagi Autologous skin cell suspensions and partial thickness paediatric burns: The BRACS Trial Protocol. Presented at Australian & New Zealand Burn Association Annual Scientific Meeting; 2018 October 16-19; Brisbane, QLD, Australia
  • PRESENTATION: J Holmes. Establishing the Safety and Effectiveness of RECELL® as an Autograft-sparing Technology for Definitive Closure of Burn Injuries. Presentation at Southern Region Burn Conference 2018; 2018 November 8-11; Mobile, AL, USA.
    CPT001-5/-6
  • PRESENTATION: W Hickerson. Resource Use, Costs and Outcomes for Treatment of Severe Burns Using RECELL® in the United States. Presentation at Southern Region Burn Conference 2018; 2018 November 8-11; Mobile, AL, USA.
    HECON
  • PRESENTATION: Braxton. Treatment of High-voltage Electrical Burn with Autologous Skin Cell Suspension: A Case Report. Presentation at Southern Region Burn Conference 2018; 2018 November 8-11; Mobile, AL, USA.
    Case Study
  • POSTER: S Kahn. Utilizing Novel Techniques and Technology in the Management of a 60 Year Old with 82% TBSA Full-Thickness Burn Injury. Presentation at Southern Region Burn Conference 2018; 2018 November 8-11; Mobile, AL, USA.
    Case Study
  • PRESENTATION: J Shupp. Establishing the Safety and Effectiveness of RECELL® as an Autologous Autograft-sparing Technology for Definitive Wound Closure of Burn Injuries. Presentation at Northeastern Burn Conference 2018; 2018 November 9-10; Cambridge, MA, USA.
    CPT001-5/-6
  • DIGITAL POSTER: P Glat. The Use of an Autologous Cell Harvesting and Processing Device in Two Burn Patients at an Urban Pediatric Burn Center. Presentation at Northeastern Burn Conference 2018; 2018 November 9-10; Cambridge, MA, USA.
    Case Studies
  • PRESENTATION: J Shupp. New Innovations – RECELL® Device Overview. Presentation at Northeastern Burn Conference 2018; 2018 November 9-10; Cambridge, MA, USA.
  • PRESENTATION: Guo Yufeng. Application of RECELL® in arc injury wounds. The 6th Oriental Congress of Burns and Plastic Medicine OCBP 2018; 2018 December 1st; Shanghai, China.
  • PRESENTATION: J Zhu. Randomized Clinical Trial of Autologous Skin Cell Suspension Combined with Grafting for Chronic Wounds. Presentation at ISBI 2018; 2018 November 30 – December 4; New Delhi, India.
  • PRESENTATION: A Jain. Compassionate Use of RECELL® and Meshed Autografts in Patients with Extensive Burn Injury.  Presentation at ISBI 2018; 2018 November 30 – December 4; New Delhi, India.
  • PRESENTATION: Duteille. Autologous Spray-on Skin to Improve Meshed Skin Graft. Presentation at ISBI 2018; 2018 November 30 – December 4; New Delhi, India.
  • PRESENTATION: J Zhu. Cost-effectiveness of an Autologous Regenerative Epithelial Suspension Versus Standard of Care for Treatment of Severe Burns in the United States. Presentation at ISBI 2018; 2018 November 30 – December 4; New Delhi, India.

2017

  • PRESENTATION: JH Holmes, JA Molnar, JW Williams, CK Craig, JE Carter.  Compassionate use of RECELL® in large burns: A single-center U.S. experience. Presented at the American Burn Association (ABA); 2017 March 21-24; Boston, MA, USA.
    CTP004
  • PRESENTATION: J Shupp. RECELL® and Regenerative Epithelial Suspension (RES).  Presented at the Northeast Region Burn Conference, 2017 Sep 22-23; Philadelphia, PA, USA.
    Case from CTP004 (Holmes case) and one of his own from CTP001-6
  • PRESENTATION: KN Foster. Compassionate Use of RECELL® & Meshed Autografts in Patients with Extensive Burn Injuries. Presented at the Midwestern Region Burn Conference, 2017 Oct 4-5; Kansas City, MO, USA.
    CTP004
  • PRESENTATION: D Roggy, and R Sood. The Use of Cultured Epithelial Autografts and Spray Keratinocytes to Provide Wound Coverage in Large TBSA Burns. Presented at the Eastern Great Lakes Region Burn Conference, 2017 Oct 12-13; Rochester, NY, USA.
    CTP004
  • POSTER: P Glat, D Wellington, A Nanassy, B Burkey, L Gates, V Adlakha. The Use of RECELL® in a Pediatric Burn Patient at an Urban Burn Center. Poster presented at the Eastern Great Lakes Region Burn Conference, 2017 Oct 12-13; Rochester, NY, USA.
    CTP004
  • PRESENTATION:  N Walker, RE Rebowe, L Allred, JH Holmes, JA Molnar, JE Carter. Initial Experience with RECELL® for Face Burns. Presented at the Southern Region Burn Conference, 2017 Nov 03-05; Miami, FL, USA.
    CTP004
  • POSTER: B Hartman, M Zieger, D Roggy, R Sood. A Prospective Evaluation of Spray Keratinocytes to Treat Large TBSA Injuries. Presented at the Southern Region Burn Conference, 2017 Nov 03-05; Miami, FL, USA.
    CTP004
  • PRESENTATION: JE Carter. Establishing the Effectiveness of RECELL® as an Autograft-Sparing Technology for Definitive Closure of Burn Injuries.  Presented at the Chinese Burns Association (CBA) and International Burns Academic Forum, 2017 Oct 25-28; Wuxi, China.
    CTP001-5/-6 and CTP004
  • PRESENTATION: JH Holmes, JA Molnar, CK Craig, JW Williams, JE Carter.  The Compassionate use of RECELL® in treating major burns: A single-center experience. Presented at the Japanese Society for Burn Injuries (JSBI), 2017.
    CTP004
  • POSTER: SE Uitentuis, KJ Willemsen, JE Lommerts, L Komen, A Wolkerstorfer, RM Luiten. Impact of graft cell density and viability on repigmentation upon non-cultured autologous cell suspension transplantation in vitiligo. Poster presented at International Pigment Cell Conference (IPCC); 2017 August 26-30; Denver, CO.
  • PRESENTATION: W Hickerson. RECELL®: An Effective Device for the Treatment of Acute Burn Injuries. Presented at European Burn Association (EBA) Symposium; 2017 September 6-9; Turin, Italy.
  • PRESENTATION: J Holmes. Establishing the Effectiveness of RECELL® as an Autograft-sparing Technology for Definitive Closure of Burn Injuries. Presented at European Burn Association (EBA) Symposium; 2017 September 6-9; Turin, Italy.
  • POSTER: Z Liu, W Li, A Zeng, Z Meng, S Cheng, C Xu, Y Tao, Z Shen, S Zhang, Z Li. Is suction blister epidermal grafting a simple and reliable way to screen patients with large area vitiligo for RECELL® treatment? Poster presented at European Society for Dermatological Research (ESDR); 2017 September 27-30; Salzberg, Austria.
  • PRESENTATION: WW Li. A new method to improve the efficacy of RECELL® technology in patients with stable vitiligo — Foaming. Presented at Resident Abstract Sessions at Plastic Surgery; 2017 October 6-8; Orlando, FL.
  • POSTER: IM Smith. Use of regenerative skin suspension in the treatment of complex de-gloving injury. Poster Presented at Wounds UK; November 13-15; Harrogate, UK.

2016

  • PRESENTATION: JH Holmes, RE Rebowe, JA Molnar, JW Williams, CK Craig, JE Carter. The Compassionate Use of RECELL® in Treating Major Burns: A single-center US Experiences.  Presented at the International Society of Burn Injuries (ISBI); 2016 Aug 29-Sep 01; Miami, FL, USA.
    CTP004
  • PRESENTATION: JH Holmes, JA Molnar, JW Williams, CK Craig, JE Carter.  Compassionate use of RECELL® in large burns: A single-center U.S. experience. Presented at the Scientific Meeting of the Australian & New Zealand Burn Association (ANZBA); 2016 Oct 11-14; Auckland, New Zealand.
    CTP004
  • PRESENTION: LJ Allred, RE Rebowe, JA Molnar, JH Holmes, JA Molnar.  Initial Experience with RECELL® for Face Burns. Presented at the Southern Region Burn Conference; 2016 Nov 04-Nov 06, 2016; Atlanta, GA, USA.
    CTP004
  • POSTER: A Tan, N Whybro, Q Frew, D Barnes, N El-Muttardi, P Dzeiwulski, B Philip. The use of RECELL® in a Regional Burn Service – Our Experience. Poster presented at the Scientific Meeting of the Australian & New Zealand Burn Association (ANZBA); 2016 Oct 11-14; Auckland, New Zealand.
  • PRESENTATION: S Manoharan. RECELL® Autologous Cell Harvesting Device in the Treatment of Challenging Indications and Skin Types. Presented at American Society for Aesthetic Plastic Surgery (ASAPS); 2016
  • PRESENTATION: C Dunnill. Scientific evaluation of autologous skin cell suspensions. Presented at European Burn Association (EBA) Educational Course; 2016 September 26-27; Birmingham, UK.
  • ELECTRONIC POSTER: P Hayes, K Harding, S Johnson, C McCollum, K Mercer, D Russell, L Teot. The effectiveness of autologous cell suspensions to elicit positive changes in quality of life in patients with venous leg ulcers. Poster presented at European Wound Management Association (EMWA); 2016 May 11-13; Bremen, Germany.
  • ELECTRONIC POSTER: R Manton, N Cavale. Treatment of Pretibial Laceration in the Outpatient Department with Autologous Non-Cultured Cell Therapy. Poster presented at European Wound Management Association (EMWA); 2016 May 11-13; Bremen, Germany.
  • ELECTRONIC POSTER: T O’Neill, J Wiper, I Smith. Use of Autologous Skin Cell Suspensions to Heal Complex Chronic Wounds. Poster presented at European Wound Management Association (EMWA); 2016 May 11-13; Bremen, Germany.
  • POSTER: E Cochrane, D Othman, A Ara, J Rawlins, M Anwar. Retrospective Analysis of Long-Term Scarring, Dyspigmentation and Itching Outcomes of Partial-Thickness Paediatric Scalds Treated with Conventional Dressings, Biobrane®, RECELL® and Split Skin Grafting at a Regional Burn Centre. Poster presented at American Burn Association (ABA); 2016 May 3-6; Las Vegas, NV.

2015

  • POSTER: D Hammer, JL Rendon, B Martin, K Latham, ME Fleming, IL Valerio. Restorative Spray Skin Technology and Reduction of Skin Graft Donor Site Burden: A Comparative Pilot Study.  Presented at the Military Health System Research Symposium (MHSRS); Aug 2015.
    CTP004
  • POSTER: K Foster, K Richey, M Pressman, D Caruso. Compassionate Use of RECELL® and Meshed Autografts in Three Patients with Extensive Burn Injury. Poster presented at the American Burn Association (ABA); 2015 April 21-24; Chicago, IL, USA.
    CTP004
  • PRESENTATION: RE Rebowe, JW Williams, CK Craig, JE Carter, JA Molnar, JH Holmes. Compassionate use of RECELL® in large burns: A single-center U.S. experience. Presented at the Southern Region Burn Conference; 2015 November 20-22; Dallas, TX, USA.
    CTP004
  • POSTER: G Goodman. RECELL® expands options in the treatment of hypopigmentation. Poster presented at Australasian College of Dermatologists (ACD); 2015 May 16-19; Adelaide, South Australia.
  • POSTER: T Woodrow, H Chant. Experience with autologous skin cell suspension in a complex foot wound. Poster presented at College of Podiatry; 2015 November 19-21; Yorkshire, UK.
  • POSTER: A Tan, N Whybro, Q Frew, D Barnes, N El-Muttardi, P Dzeiwulski, B Philip. The Use of RECELL® in a Regional Burn Service. Poster presented at European Burns Association (EBA); 2015 September 16-19; Hannover, Germany.
  • POSTER: A Tan, S Ramadan, J Yarrow, N El-Muttardi, B Philip, P Zeiwulski. The role of RECELL® in Burns and Plastic Surgery Services – An Evidence Based Approach. Poster presented at European Burns Association (EBA); 2015 September 16-19; Hannover, Germany.
  • PRESENTATION: K Busch, R Bender, N Walezko, M Aust. Combination of Medical Needling and RECELL® for Repigmentation of Burn Scars. Presented at European Burns Association (EBA); 2015 September 16-19; Hannover, Germany.
  • PRESENTATION: T Woodrow, H Chant. Experience with Autologous Skin Cell Suspension (ASCS) in a Complex Foot Wound. Presented at European Wound Management Association (EWMA); 2015 May 13-15; London, UK.
  • POSTER: D Hammer, J Rendon, B Martin, K Latham, M Fleming, I Valerio. Restorative Spray Skin Technology and Reduction of Skin Graft Donor Site Burden: A Comparative Pilot Study. Poster presented at Military Health System Research Symposium (MHRS); 2015 August 17-20, Ft. Lauderdale, FL.
  • POSTER: M Fleming, I Valerio. Regeneration of a Full Thickness Soft Tissue Defect with Autologous Spray Skin Epidermal Regenerative Technology in Conjunction with a Dermal Regenerate Template and Widened Meshed STSG. US National Capital Region Research Competition; 2015

2014

  • E-POSTER: Wolkerstorfer. Vitiligo-Piebaldism. Presented at American Society for Laser Medicine and Surgery (ASLMS); 2014 April 2-6; Phoenix, AZ.
  • POSTER: JA Dunne, JM Rawlins. A Systematic Review of the Management of Acute Burn Injuries with RECELL®. Presented at British Burn Association (BBA); 2014; Chelmsford, UK.
  • POSTER: JA Dunne, A Murray, JM Rawlins. A Survey of Skin Substitute Use in the United Kingdom and Australasia. Presented at British Burn Association (BBA); 2014; Chelmsford, UK.
  • POSTER: L Komen, C Vrijman, PM Tjin, G Krebbers, MA de Rie, RM Luiten, JP Wietze van der Veen, A Wolkerstorfer. Autologous cell suspension transplantation using a cell harvesting device in segmental vitiligo and piebaldism patients: a randomized controlled pilot study. Presented at the International Pigment Cell Conference (IPCC); 2014.
  • PRESENTATION: J Holmes. RECELL® in Massive Burn Injury. Presented at International Society for Burn Injuries (ISBI); 2014.
  • PRESENTATION: M Aust, R Bender, N Walezko, K Busch. Combination of Needling and RECELL® for repigmentation of burn scars – a promising approach? Presented at International Society for Burn Injuries (ISBI); 2014.
  • PRESENTATION: F Wood. The use of cell based therapies in scar prevention and remodelling. Presented at International Society for Burn Injuries (ISBI); 2014.
  • PRESENTATION: F Wood. The role of cell based therapies in burn wound healing. Presented at International Society for Burn Injuries (ISBI); 2014.
  • PRESENTATION: F Wood. The use of cell based therapies. Presented at International Society for Burn Injuries (ISBI); 2014.
  • PRESENTATION: R Ur, JE Carter, JA Molnar, JH Holmes. Compassionate Use of RECELL® in a Massive Burn Injury. Presented at SRBC; 2014; Houston, TX.
  • PRESENTATION: R Bender, M Aust, N Walezko, K Busch. Presented at VDAPC; 2014; Frankfurt, Germany.
  • POSTER: G Curran, P Shipley-Cribb, K Brown, P Hayes. The Study Design of a Pilot Randomised Controlled trial of RECELL® for the Treatment of Venous Leg Ulcers. Presented at Wounds; 2014; UK.

2013

  • PRESENTATION: AM Murray, H Le Cocq, P Webster, J Rawlins. Early Intervention and Autologous Cell-Based Therapy – are they Cost Effective? Presented at Australia and New Zealand Burn Association (ANZBA); 2013 October 15-18; Fremantle, Australia.
  • PRESENTATION: JA Dunne, JM Rawlins. Management of Deep Dermal Burn Wounds with Biobrane® and RECELL® – Our Experience. Presented at Australia and New Zealand Burn Association (ANZBA); 2013 October 15-18; Fremantle, Australia.
  • PRESENTATION: M Aust, K Busch. Combination of Needling and RECELL® for repigmentation of burn scars – a promising approach? Presented at CCR; 2013; London, UK
  • PRESENTATION: R Zajicek, R Kubok, E Matouskova, L Broz. Using the combination of autologous cell suspension (Re-Cell) and acellular pig dermis (Xe-Derma) in the treatment of pediatric patient with 90% full thickness skin loss. Presented at European Burn Association (EBA); 2013.

2012

  • PRESENTATION: E Giraldi. Not in English. Presented at Associaiazione Italiana Ulcere Cutanee Onlus (AIUC); 2012 September 26-29.
  • POSTER: MC Aust, J Vorhold, H Aziz, T Rohn, KH Busch. Combination with Needling and Tecell for repigmentation. Presented at German Society of Plastic, Reconstructive and Aesthetic Surgeons (DGPRAC). 2012.
  • POSTER: K Echlin, B Way, J Leon-Villapalos, J Atkins, G Williams, I Jones. The Use of Autologous Non-Cultured Epidermal Cells on Split Thickness Donor Sites. Presented at International Society of Burn Injuries (ISBI); 2012 September 9-13; Edinburgh, UK.
  • PRESENTATION: M Palombo, A Bruno, G delli Santi, T Anniboletti, S Moroni, P Palombo. Our Experience with RECELL®: A Panel of Cases. Presented at International Society of Burn Injuries (ISBI); 2012 September 9-13; Edinburgh, UK.

2011

  • POSTER: B De Angelis, L Lucarini, A Agovino, V Cervelli. RECELL®: A new device for skin autologous implants in the treatment of burns and scars.
  • PRESENTATION: JM Rawlins, J Signy, S Rea, FM Wood. Biobrane with RECELL® for the Treatment of Deep Dermal Burns to the Legs – A Comparative Pilot Study. Presented at American Burn Association (ABA); 2011 April 29-March 1; Chicago, IL
  • PRESENTATION: JM Rawlins. Early surgery for ALL paediatric scalds – developing a dermal preserving surgical protocol for the benefit of patients and health care providers. Presented at American Burn Association (ABA); 2011 April 29-March 1; Chicago, IL
  • POSTER: R Sood. Opportunities for RECELL® Autologous Cell Harvesting in Burns and Delayed Healing. Poster presented at British Burn Association (BBA); 2011 Salibury, UK.
  • POSTER: TB O’Neill, J Rawlins, S Rea, F Wood. Treatment of a large congenital melanocytic nevus with dermabrasion and autologous cell suspension (RECELL®). Poster presented at IAPS; 2011.
  • PRESENTATION: H Rennekampff, C Herold, M Vogt. Keratinocyte suspension for the treatment of facial burns. Presented at the International Society of Burn Injuries (ISBI); 2011.

2009

  • PRESENTATION: B De Angelis, L Lucarini, A Montone, V Cervelli. RECELL®: A new device for skin autologous implants in the treatment of burns and scars. Presented at European Burns Association (EBA); 2009 September 2-5; Lausanne, Switzerland.
This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our privacy policy.